Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in mammalian cells
Type of information:
experimental study
Adequacy of study:
key study
Study period:
No data
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1991

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
other: 40 CFR Part 158 US-EPA-FIFRA, Section 156.340
Deviations:
no
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
Deviations:
not specified
GLP compliance:
yes
Type of assay:
mammalian cell gene mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Boric acid
EC Number:
233-139-2
EC Name:
Boric acid
Cas Number:
10043-35-3
Molecular formula:
H3BO3
IUPAC Name:
Boric acid
Details on test material:
- Name of test material: Boric acid, Granular Technical Grade; Granular Technical Grade Supplied by US Borax Inc.
- Analytical purity: > 99 %
- Stability: Stable

Method

Target gene:
Thymidine kinase, TK locus of the L5178Y mouse lymphoma cell line
Species / strain
Species / strain / cell type:
mouse lymphoma L5178Y cells
Details on mammalian cell type (if applicable):
No data
Additional strain / cell type characteristics:
not specified
Metabolic activation:
with and without
Metabolic activation system:
S9 mix or other (Aroclor 1254 induced rat (Fischer 344) liver S9 fraction used at 1 %).
Test concentrations with justification for top dose:
0, 1.2, 1.7, 2.45, 3.5 and 5.0 mg/mL boric acid.
Vehicle / solvent:
No data
Controlsopen allclose all
Positive controls:
yes
Positive control substance:
3-methylcholanthrene
Positive controls:
yes
Positive control substance:
other: Hycanthone methylsulphonate
Details on test system and experimental conditions:
METHOD OF APPLICATION: ROP plus 5 % heat treated horse serum

NUMBER OF CELLS EVALUATED: Approximately 600/dose
Evaluation criteria:
Mutations at the TK locus
Statistics:
No data

Results and discussion

Test results
Species / strain:
mouse lymphoma L5178Y cells
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
Concentration related cytoxicity (60 % reduction over controls at 5 mg/mL)
Additional information on results:
Concentration related cytotoxicity (60 % reduction over controls at 5 mg/mL).
Increase in ouabain resistance seen (not significant).
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Gene mutation assay results:

Concentration

mg/mL

Number of mutant cells per 106cells ± SD

Comments give information

on cytotoxicity or other

Exp 1

Exp 2

Exp 1

Exp 2

-S9

-S9

+S9

+S9

0

54 ± 10

42 ± 1

29 ± 10

36 ± 7

 

1.2

46 ± 28

38 ± 15

34 ± 0

36 ± 7

 

1.7

39 ± 17

31 ± 9

41 ± 7

49 ± 4

 

2.45

27 ± 3

32 ± 9

40 ± 16

36 ± 6

Minor cytotoxicity seen

3.5

31 ± 18

46 ± 1

41 ± 13

41 ± 6

Cytotoxicity seen

5

50 ± 22

41 ± 5

53 ± 2

47 ± 3

Cytotoxicity seen. Increase in + S9 in first study not reproduced.

Applicant's summary and conclusion

Conclusions:
The test substance was not mutagenic but cytotoxicity observed at 5 mg/mL (maximum dose level).